十年来首支新型减肥药BELVIQ(必维克)获美国FDA批准
十年来首支新型减肥药BELVIQ(必维克)获美国FDA批准: 美国FDA对研制的减肥药要求必须有很高的安全性。1997年,减肥药芬氟拉明就因导致心脏瓣膜的健康问题而被禁下架。在过去的几年中,美国FDA以健康隐患和减肥疗效不佳为由共拒绝批准多个减肥药。
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.